XML 21 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 253,123 $ 306,235
Marketable securities 768,278 212,613
Prepaid expenses and other current assets 18,511 6,227
Total current assets 1,039,912 525,075
Property and equipment, net 5,168 4,013
Restricted cash 1,919 849
Total assets 1,046,999 529,937
Current liabilities:    
Accounts payable 5,879 9,350
Accrued expenses 48,647 42,601
Total current liabilities 54,526 51,951
Other liabilities 3,968 2,511
Total liabilities 58,494 54,462
Commitments and contingencies (Note 5)
Stockholders’ equity:    
Preferred stock, $0.0001 par value per share; 5,000,000 shares authorized at September 30, 2018 and December 31, 2017; no shares issued or outstanding at September 30, 2018 and December 31, 2017
Common stock, $0.0001 par value per share; 120,000,000 shares authorized at September 30, 2018 and December 31, 2017; 46,832,103 and 42,003,894 shares issued at September 30, 2018 and December 31, 2017, respectively; 46,830,589 and 42,002,934 shares outstanding at September 30, 2018 and December 31, 2017, respectively 5 5
Treasury stock, at cost, 1,514 and 960 shares at September 30, 2018 and December 31, 2017, respectively (211) (113)
Additional paid-in capital 1,793,909 1,066,059
Accumulated deficit (804,941) (590,447)
Accumulated other comprehensive loss (257) (29)
Total stockholders’ equity 988,505 475,475
Total liabilities and stockholders’ equity $ 1,046,999 $ 529,937